- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Glial fibrillary acid protein (GFAP) antibody and antigen (Recombinant protein)
Diagnostic Glial fibrillary acid protein (GFAP) antibodies (anti-Glial fibrillary acid protein, anti-GFAP) and antigens (recombinant Glial fibrillary acid protein (GFAP) protein) for Neurodegenerative diseases GFAP detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection
>>
제품 정보
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-GFAP-Ag01 | Recombinant human GFAP Protein | $3090.00 |
| GMP-h-GFAP-Ab01 | Anti-human GFAP mouse monoclonal antibody (mAb) | $1953.00 |
| GMP-h-GFAP-Ab02 | Anti-human GFAP mouse monoclonal antibody (mAb) | $1953.00 |
| GMP-h-GFAP-Ab03 | Anti-human GFAP human monoclonal antibody (mAb) | $1953.00 |
| GMP-h-GFAP-Ab04 | Anti-human GFAP human monoclonal antibody (mAb) | $1953.00 |
Size： 1mg | 10mg | 100mg
제품 설명
| Cat No. of Pruducts | GMP-h-GFAP-Ag01 |
| Product Name | Recombinant human GFAP Protein |
| Target/Biomarker | Glial fibrillary acid protein (GFAP) |
| Alias of Target/Biomarker | ALXDRD |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Glial fibrillary acid protein (GFAP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GFAP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation |
| Products description | Recombinant Human Glial fibrillary acid protein (GFAP) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Pruducts | GMP-h-GFAP-Ab01,GMP-h-GFAP-Ab02 |
| Product Name | Anti-human GFAP mouse monoclonal antibody (mAb) |
| Target/Biomarker | Glial fibrillary acid protein (GFAP) |
| Alias of Target/Biomarker | ALXDRD |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Glial fibrillary acid protein (GFAP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Glial fibrillary acid protein (GFAP) antibodies in GFAP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human GFAP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Glial fibrillary acid protein (GFAP) antibodies. |
| Reconized/Reactive Species | Human |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Pruducts | GMP-h-GFAP-Ab03,GMP-h-GFAP-Ab04 |
| Product Name | Anti-human GFAP human monoclonal antibody (mAb) |
| Target/Biomarker | Glial fibrillary acid protein (GFAP) |
| Alias of Target/Biomarker | ALXDRD |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human Glial fibrillary acid protein (GFAP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Glial fibrillary acid protein (GFAP) antibodies in GFAP level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human GFAP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Reconized/Reactive Species | Human |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
참고 문헌
검증 데이터
Click to get more Data / Case study about the product.
Target/Biomarker 정보
Glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein, can be measured in blood samples, and has been associated with Alzheimer's disease (AD)
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments
No comments yet.